P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

February 2004

Features

Book Review

Dr. David Sherer’s Hospital Survival Guide

A valuable book provides practical advice for readers and their families about how to prepare for surgery.
Adam Evans

Focus on Medicare

Medicare and the New Generic Drug Legislation

Dr. Goldenberg discusses how Hatch–Waxman “got the hatchet.”
Marvin M. Goldenberg, PhD, RPh, MS

The Medicare Modernization Act (MMA): How Will It Affect P&T Committee Members?

Dr. Stefanacci addresses some unanswered questions about the new Medicare drug benefit; for example, how many drugs will be needed to meet the formulary requirement, how will the formularies be designed, and how will the appeals process work?
Richard G. Stefanacci, DO, MGH, MBA, CMD

Meeting Highlights

Highlights of the 45th Annual Meeting of the American Society of Hematology

Dr. Prescott reports on new therapies for non-Hodgkin’s and mantle-cell lymphomas, myeloid and myelomonocytic leukemias, myelodysplastic syndromes, myelodysplasia, oral mucositis, polycythemia vera, and other disorders of the blood.
Lawrence M. Prescott, PhD

Continuing Education Credit

Current Recommendations for the Treatment of Dyslipidemia

Dr. Talbert reviews current therapies for lipid disorders and emphasizes the need for monitoring patients and promoting their adherence to treatment guidelines.
Robert L. Talbert, PharmD, BCPS

CE Forms and Test for “Current Recommendations for the Treatment of Dyslipidemia”

Departments

Editorial

Seeking Middle Ground

David Nash, MD, MBA, discusses the need for health care providers and drug companies to “seek middle ground” in avoiding conflicts of interest.
David B. Nash, MD, MBA

Prescription Washington

House of Cards: New Medicare Drug Cards Built on Rickety Assumptions

Stephen Barlas perceives some pitfalls with the new Medicare Drug Discount Cards.
Stephen Barlas

Medication Errors

Maintaining Patient Safety in the Midst of Staff Reductions

Matthew Grissinger, RPh, FASCP, stresses the need to maintain patient safety despite the current trend of staff reductions.
Matthew Grissinger, RPh, FASCP

P&T Snapshot

Hospital Treatment Patterns for Dyslipidemia

Drug News

New Drugs/Drug News

P&T presents the latest studies and information about FDA approvals, drug indications, industry updates, and new medical devices.

Drug Forecast

FluMist™: A Live, Attenuated Influenza Vaccine

Drs. Hilas and Marzella review FluMist™, a live, attenuated influenza vaccine.
Olga Hilas, BS, PharmD, and Nino Marzella, BS, PharmD